Do muscle relaxants such as methocarbamol affect muscle growth?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Methocarbamol Does Not Affect Muscle Growth

Methocarbamol and other centrally-acting muscle relaxants do not directly affect muscle growth or muscle tissue itself. These medications work through central nervous system depression rather than by acting on skeletal muscle fibers, contractile mechanisms, or muscle protein synthesis 1.

Mechanism of Action

Methocarbamol is a centrally-acting skeletal muscle relaxant that does not act directly on skeletal muscle 2. The FDA label explicitly states that "methocarbamol does not directly relax tense skeletal muscles in man" 1. Its mechanism involves general CNS depression rather than any direct effect on:

  • The contractile mechanism of striated muscle
  • The motor end plate
  • Nerve fibers
  • Muscle protein synthesis or breakdown 1

Evidence on Muscle Function

While methocarbamol doesn't affect muscle growth, research shows it does have peripheral effects on muscle function (not growth):

  • Blocks muscular Nav 1.4 sodium channels, which affects muscle contraction but not muscle tissue development 3
  • Reduces isometric muscle force during active contraction, but this is a temporary functional effect, not a structural change 3
  • Affects muscle spindle function and proprioception, which could theoretically impair exercise performance feedback mechanisms 4

However, one study found methocarbamol does not significantly affect EMG fatigue markers during muscle performance testing 5, and another concluded that muscle relaxants "do not cause measurable muscle relaxation following usual oral dosage regimens" 6.

Clinical Implications for Muscle Growth

There is no evidence that methocarbamol interferes with muscle hypertrophy, protein synthesis, or long-term muscle development. The drug's effects are:

  • Temporary and functional (affecting contraction during active use)
  • Reversible when the drug is discontinued 3
  • Not structural (no impact on muscle tissue architecture or growth pathways)

The 2020 JAGS guideline notes these drugs "do not directly relax skeletal muscle" and their effects are "nonspecific and not related to muscle relaxation" 7. This confirms they work through sedation rather than muscle tissue modification.

Important Caveats

While methocarbamol doesn't affect muscle growth directly, consider these practical concerns:

  • Sedation and CNS depression may reduce exercise intensity or training consistency 2
  • Reduced proprioception from muscle spindle effects could impair exercise technique 4
  • Decreased muscle force output during active use might limit training stimulus 3

These functional impairments during active medication use could indirectly reduce training effectiveness, but this is different from the drug directly inhibiting muscle growth mechanisms.

Bottom line: Methocarbamol can be used for acute musculoskeletal pain without concern for direct interference with muscle growth, though its sedative effects may temporarily reduce training capacity while actively taking the medication.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.